Ruinan Lu

机构：USC Norris Comprehensive Cancer Center

发表论文 50 篇 · 总被引 598 次 · h-index 13

代表论文

• Interleukin-6 (IL-6)-associated tumor microenvironment remodelling and cancer immunotherapy (2025 · Cytokine & Growth Factor Reviews · 被引 54)
• Plasma levels of S100A8/A9, histone/DNA complexes, and cell‐free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura (2020 · Journal of Thrombosis and Haemostasis · 被引 32)
• Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases (2018 · Cancer Research and Treatment · 被引 29)
• Elevated plasma levels of syndecan-1 and soluble thrombomodulin predict adverse outcomes in thrombotic thrombocytopenic purpura (2020 · Blood Advances · 被引 20)
• Reduced-dose chemotherapy and blinatumomab as induction treatment for newly diagnosed Ph-negative B-cell precursor acute lymphoblastic leukemia: a phase 2 trial (2024 · Journal of Hematology & Oncology · 被引 15)
• Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma (2018 · Annals of Hematology · 被引 13)